Are Mast Cells Still Good Biomarkers for Bladder Pain Syndrome/Interstitial Cystitis?
- 1 June 2015
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 193 (6), 1994-2000
- https://doi.org/10.1016/j.juro.2015.01.036
Abstract
ESSIC identifies mast cell infiltrates of detrusor muscle as a diagnostic criterion for bladder pain syndrome/interstitial cystitis. However, an increased mast cell count is also characteristic of overactive bladder syndrome. The lack of uniformity in mast cell detection methods hampers data comparison. Using state-of-the-art techniques we investigated whether mast cells differ among bladder conditions.We analyzed bladder biopsies from 56 patients, including 31 with bladder pain syndrome/interstitial cystitis with (12) or without (19) Hunner lesions, 13 with overactive bladder syndrome and 12 without bladder symptoms to determine the quantity, location, distribution and activation of mast cells using immunohistochemistry with anti-mast cell tryptase. Patients were allocated to study groups by key bladder symptoms commonly used to define conditions (pain and major urgency).Subepithelial mast cell localization (p <0.001) and an increased detrusor mast cell count (p = 0.029) were characteristic of bladder pain syndrome/interstitial cystitis with Hunner lesions. The optimal cutoff of 32 detrusor mast cells per mm(2) achieved only 68% accuracy with 38% positive predictive value. No difference was observed between bladder pain syndrome/interstitial cystitis without Hunner lesions and overactive bladder syndrome. Patient groups differed in lymphocyte infiltration (p = 0.001), nodular lymphocyte aggregates (p <0.001) and urothelium integrity (p <0.001).Subepithelial mast cell distribution was characteristic of bladder pain syndrome/interstitial cystitis with Hunner lesions. Detrusor mastocytosis had poor predictive value for bladder pain syndrome/interstitial cystitis. Mast cell assessment did not distinguish bladder pain syndrome/interstitial cystitis without Hunner lesions from overactive bladder syndrome.Keywords
This publication has 22 references indexed in Scilit:
- Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences?International Journal of Clinical Practice, 2013
- Differences in Mast Cell Infiltration, E-cadherin, and Zonula Occludens-1 Expression Between Patients With Overactive Bladder and Interstitial Cystitis/Bladder Pain SyndromeUrology, 2012
- Quantifying mast cells in bladder pain syndrome by immunohistochemical analysisBJU International, 2008
- Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC ProposalEuropean Urology, 2008
- Primary Evaluation of Patients Suspected of Having Interstitial Cystitis (IC)European Urology, 2004
- Mast cell involvement in interstitial cystitis: a review of human and experimental evidenceUrology, 2001
- RECRUITMENT, DISTRIBUTION AND PHENOTYPES OF MAST CELLS IN INTERSTITIAL CYSTITISJournal of Urology, 2000
- Clinical Features and Spectrum of Light Microscopic Changes in Interstitial CystitisJournal of Urology, 1990
- Mast Cell Involvement in Interstitial CystitisJournal of Urology, 1987
- Mast Cells in Interstitial CystitisBritish Journal of Urology, 1982